According to Alaunos Therapeutics's latest financial reports the company has $6.06 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $39.05 M | -48.64% |
2021-12-31 | $76.05 M | -33.91% |
2020-12-31 | $0.11 B | 44.3% |
2019-12-31 | $79.74 M | 29.18% |
2018-12-31 | $61.72 M | -12.99% |
2017-12-31 | $70.94 M | -12.47% |
2016-12-31 | $81.05 M | -42.4% |
2015-12-31 | $0.14 B | 228.75% |
2014-12-31 | $42.8 M | -37.24% |
2013-12-31 | $68.2 M | -6.96% |
2012-12-31 | $73.3 M | -29.99% |
2011-12-31 | $0.10 B | 73.39% |
2010-12-31 | $60.39 M | 23.66% |
2009-12-31 | $48.83 M | 329.2% |
2008-12-31 | $11.37 M | -67.52% |
2007-12-31 | $35.02 M | 23.29% |
2006-12-31 | $28.41 M | 219.91% |
2005-12-31 | $8.88 M | 765.01% |
2004-12-31 | $1.02 M | 3110978.79% |
2003-12-31 | $0 M | 120% |
2002-12-31 | $0 M | -96.67% |
2001-12-31 | $0 M |